Patents by Inventor Bernard Muellinger

Bernard Muellinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Flow and volume regulated inhalation for treatment of severe oral corticosteroid-dependent asthma
    Patent number: 8834848
    Abstract: A drug and device combination system used in a method for treatment of patients suffering from severe and oral corticosteroid-dependent asthma and other respiratory diseases requiring a treatment with orally administered steroids. The method for administration of the inhalable corticosteroid by a flow rate and volume regulated inhalation. The combination system of the inhalable corticosteroid and the device for regulating flow rate and volume of the inhalable corticosteroid and thus achieving delivery of said inhalable corticosteroid into the small airways of the lungs. The individually programmable device that assures safe and reproducible corticosteroid delivery compliant with treatment protocol.
    Type: Grant
    Filed: September 6, 2012
    Date of Patent: September 16, 2014
    Assignee: Activaero GmbH Research & Development
    Inventors: Bernard Muellinger, Gerhard Scheuch, Thomas Hofmann, Philipp Kroneberg
  • Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma
    Patent number: 8668901
    Abstract: Methods, devices and compositions for treatment of severe and uncontrolled asthma are provided by which high amounts of an inhaled corticosteroid are directed to the small airways of the lower lungs. The invention provides for a substantial decrease in the dose of concurrently administered oral corticosteroids. A particular advantage of the invention is the significant reduction in corticosteroid-related adverse effects.
    Type: Grant
    Filed: February 3, 2010
    Date of Patent: March 11, 2014
    Assignee: Activaero GmbH Research & Development
    Inventors: Bernard Muellinger, Gerhard Scheuch, Thomas Hofmann, Philipp Kroneberg
  • Drug and Device Combination System for Flow and Volume Regulated Inhalation and a Method for Treatment of Severe Oral Corticosteroid-Dependent Asthma and Other Respiratory Diseases
    Publication number: 20130037024
    Abstract: A drug and device combination system used in a method for treatment of patients suffering from severe and oral corticosteroid-dependent asthma and other respiratory diseases requiring a treatment with orally administered steroids. The method for administration of the inhalable corticosteroid by a flow rate and volume regulated inhalation. The combination system of the inhalable corticosteroid and the device for regulating flow rate and volume of the inhalable corticosteroid and thus achieving delivery of said inhalable corticosteroid into the small airways of the lungs. The individually programmable device that assures safe and reproducible corticosteroid delivery compliant with treatment protocol.
    Type: Application
    Filed: September 6, 2012
    Publication date: February 14, 2013
    Inventors: Bernard Muellinger, Gerhard Scheuch, Thomas Hofmann, Philipp Kroneberg
  • Use of a Glucocorticoid Composition for the Treatment of Severe and Uncontrolled Asthma
    Publication number: 20120040945
    Abstract: Methods, devices and compositions for treatment of severe and uncontrolled asthma are provided by which high amounts of an inhaled corticosteroid are directed to the small airways of the lower lungs. The invention provides for a substantial decrease in the dose of concurrently administered oral corticosteroids. A particular advantage of the invention is the significant reduction in corticosteroid-related adverse effects.
    Type: Application
    Filed: February 3, 2010
    Publication date: February 16, 2012
    Applicant: ACTIVAERO GMBH RESEARCH & DEVELOPMENT
    Inventors: Bernard Muellinger, Thomas Hofmann, Gerhard Scheuch, Philipp Kroneberg